FindTrial
Sign In

CLINICAL TRIAL TO EVALUATE THE EFFICACY OF SIDDHA FORMULATION NEERIZHIVU CHOORANAM FOR DIABETIS MELLITUS

A PILOT CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF THE SIDDHA FORMULATION â??NEERIZHUVU CHOORANAMâ?? NEERIZHIVU (TYPE II DIABETIS MELLITUS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/033272
Enrollment
20
Registered
2021-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

SHARMILA P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Polyuria 2 Polyphagia 3 Polydipsia 4 loss of weight 5 HbA1c â?? 6.4 TO 10%

Exclusion criteria

Exclusion criteria: 1 Age less than 15 years 2 Above 60 years 3 Presence of CVS RS Liver and Renal disease 4 Other systemic illness Vulnerable groups 5 Not willing to give informed consent 6 Women those who are planning for pregnancy 7 HbA1c less than 6.4% 8 IDDM Signature

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Neerizhuvu chooranam in the treatment of NEERIZHIVU (Type II DIABETIS MELLITUS).Timepoint: 1 YEAR—

Secondary

MeasureTime frame
To study about the effect on symptoms like polydipsia, polyphagia, excessive and frequent urination, sweet odour in urine, presence of ants and house flies at the urinated place, loss of weight resulting in gradual deterioration of the body. Timepoint: 1 YEAR—

Countries

India

Contacts

Public ContactSHARMILA

NATIONAL INSTITUTE OF SIDDHA

christianvijila@gmail.com9962545930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026